Request Sample Inquiry
Human Insulin Market

Human Insulin Market

Human Insulin Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

205

Base Year:

2022

Date

Dec - 2024

Format:

PDF XLS PPT

Report Code:

VMR-1911

Segments Covered
  • By Product By Product Drugs, Delivery Devices
  • By Product Type By Product Type Insulin Analoys & Biosimilars, Human Insulin Biologics
  • By Diabetes Type By Diabetes Type Diabetes 1, Diabetes 2
  • By Delivery Devices By Delivery Devices Pens, Pen Needles, Syringes
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 22.66 Billion
Revenue 2030Revenue 2030: USD 28.71 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 3.00%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Human Insulin Market - Segment Analysis
    1. Overview
    2. Global Human Insulin Market, 2016 - 2028 (USD Million)
    3. Global Human Insulin Market - by Product
      1. By Drugs
      2. By Delivery Devices
    4. Global Human Insulin Market - by Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    5. Global Human Insulin Market - by Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    6. Global Human Insulin Market - by Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
    7. Global Human Insulin Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    8. Market comparative analysis
  4. North America Human Insulin Market - Segment Analysis
    1. Overview
    2. North America Human Insulin Market, 2016 - 2028 (USD Million)
    3. North America Human Insulin Market, by Product
      1. By Drugs
      2. By Delivery Devices
    4. North America Human Insulin Market, by Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    5. North America Human Insulin Market, by Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    6. North America Human Insulin Market, by Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
    7. North America Human Insulin Market, by Country
      1. U.S.
        1. U.S. Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. U.S. Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. U.S. Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. U.S. Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      2. Canada
        1. Canada Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. Canada Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. Canada Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. Canada Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      3. Mexico
        1. Mexico Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. Mexico Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. Mexico Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. Mexico Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
  5. Europe Human Insulin Market - Segment Analysis
    1. Overview
    2. Europe Human Insulin Market, 2016 - 2028 (USD Million)
    3. Europe Human Insulin Market, by Product
      1. By Drugs
      2. By Delivery Devices
    4. Europe Human Insulin Market, by Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    5. Europe Human Insulin Market, by Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    6. Europe Human Insulin Market, by Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
    7. Europe Human Insulin Market, by Country
      1. Germany
        1. Germany Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. Germany Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. Germany Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. Germany Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      2. UK
        1. UK Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. UK Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. UK Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. UK Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      3. France
        1. France Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. France Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. France Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. France Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      4. Spain
        1. Spain Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. Spain Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. Spain Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. Spain Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      5. Italy
        1. Italy Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. Italy Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. Italy Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. Italy Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      6. BENELUX
        1. BENELUX Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. BENELUX Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. BENELUX Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. BENELUX Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      7. Rest of Europe
        1. Rest Of Europe Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. Rest Of Europe Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. Rest Of Europe Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. Rest Of Europe Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
  6. Asia Pacific Human Insulin Market - Segment Analysis
    1. Overview
    2. Asia Pacific Human Insulin Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Human Insulin Market, by Product
      1. By Drugs
      2. By Delivery Devices
    4. Asia Pacific Human Insulin Market, by Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    5. Asia Pacific Human Insulin Market, by Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    6. Asia Pacific Human Insulin Market, by Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
    7. Asia Pacific Human Insulin Market, by Country
      1. China
        1. China Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. China Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. China Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. China Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      2. Japan
        1. Japan Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. Japan Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. Japan Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. Japan Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      3. India
        1. India Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. India Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. India Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. India Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      4. South Korea
        1. South Korea Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. South Korea Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. South Korea Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. South Korea Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      5. South East Asia
        1. South East Asia Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. South East Asia Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. South East Asia Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. South East Asia Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. Rest of Asia Pacific Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. Rest of Asia Pacific Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. Rest of Asia Pacific Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
  7. Latin America Human Insulin Market - Segment Analysis
    1. Overview
    2. Latin America Human Insulin Market, 2016 - 2028 (USD Million)
    3. Latin America Human Insulin Market, by Product
      1. By Drugs
      2. By Delivery Devices
    4. Latin America Human Insulin Market, by Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    5. Latin America Human Insulin Market, by Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    6. Latin America Human Insulin Market, by Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
    7. Latin America Human Insulin Market, by Country
      1. Brazil
        1. Brazil Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. Brazil Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. Brazil Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. Brazil Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      2. Argentina
        1. Argentina Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. Argentina Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. Argentina Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. Argentina Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      3. Rest of Latin America
        1. Rest of Latin America Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. Rest of Latin America Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. Rest of Latin America Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. Rest of Latin America Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
  8. Middle East & Africa Human Insulin Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Human Insulin Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Human Insulin Market, by Product
      1. By Drugs
      2. By Delivery Devices
    4. Middle East & Africa Human Insulin Market, by Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    5. Middle East & Africa Human Insulin Market, by Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    6. Middle East & Africa Human Insulin Market, by Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
    7. Middle East & Africa Human Insulin Market, by Country
      1. GCC Countries
        1. GCC Countries Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. GCC Countries Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. GCC Countries Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. GCC Countries Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      2. South Africa
        1. South Africa Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. South Africa Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. South Africa Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. South Africa Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Human Insulin Market, By Product
          1. By Drugs
          2. By Delivery Devices
        2. Rest of Middle East & Africa Human Insulin Market, By Product Type
          1. By Insulin Analoys & Biosimilars
          2. By Human Insulin Biologics
        3. Rest of Middle East & Africa Human Insulin Market, By Diabetes Type
          1. By Diabetes 1
          2. By Diabetes 2
        4. Rest of Middle East & Africa Human Insulin Market, By Delivery Devices
          1. By Pens
          2. By Pen Needles
          3. By Syringes
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Novo Nordisk A/S (Denmark)
    2. Eli Lilly & Company (US)
    3. Boston Scientific Corporation (US)
    4. Sanofi (France)
    5. Boehringer Ingelheim International GmbH (Germany)
    6. Biocon (India)
    7. Tonghua Dongbao Pharmaceutical (China)
    8. Julphar (UAE)
    9. Wockhardt (India)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 01-Dec-2022
“Human Insulin Market to Reach Valuation of USD 26.9 Billion by 2028 –Increased Launch of Novel Human Insulin Products Drives the Market”
FAQ
Frequently Asked Question

  • The global Human Insulin valued at USD 22.66 Billion in 2022 and is expected to reach USD 28.71 Billion in 2030 growing at a CAGR of 3.00%.

  • The prominent players in the market are Novo Nordisk A/S (Denmark), Eli Lilly & Company (US), Boston Scientific Corporation (US), Sanofi (France), Boehringer Ingelheim International GmbH (Germany), Biocon (India), Tonghua Dongbao Pharmaceutical (China), Julphar (UAE), Wockhardt (India).

  • The market is project to grow at a CAGR of 3.00% between 2023 and 2030.

  • The driving factors of the Human Insulin include

    • Increase in prevalence of diabetes

  • North America was the leading regional segment of the Human Insulin in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy